BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 28 filers reported holding BELLEROPHON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $11,000 | -72.5% | 17,368 | -71.7% | 0.00% | – |
| Q1 2019 | $40,000 | -23.1% | 61,348 | -6.4% | 0.00% | – |
| Q4 2018 | $52,000 | -27.8% | 65,562 | -1.8% | 0.00% | – |
| Q3 2018 | $72,000 | -53.5% | 66,766 | +4.2% | 0.00% | – |
| Q2 2018 | $155,000 | -3.7% | 64,057 | -17.3% | 0.00% | – |
| Q1 2018 | $161,000 | -4.7% | 77,452 | +18.2% | 0.00% | – |
| Q4 2017 | $169,000 | +94.3% | 65,518 | +7.3% | 0.00% | – |
| Q3 2017 | $87,000 | +38.1% | 61,033 | +28.0% | 0.00% | – |
| Q2 2017 | $63,000 | – | 47,678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 8,298,755 | $6,651,000 | 7.59% |
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 15,138,486 | $16,953,000 | 1.88% |
| VHCP Management II, LLC | 4,149,378 | $3,325,000 | 1.43% |
| VHCP Management III, LLC | 2,274,370 | $1,823,000 | 1.32% |
| ARCH Venture Management, LLC | 965,660 | $774,000 | 0.77% |
| A.R.T. Advisors, LLC | 30,484 | $24,000 | 0.00% |
| Virtu Financial LLC | 36,708 | $29,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $147,000 | 0.00% |
| GABLES CAPITAL MANAGEMENT INC. | 1,400 | $1,000 | 0.00% |
| Renaissance Technologies | 1,255,476 | $1,006,000 | 0.00% |